Status:
TERMINATED
Optimizing Preoperative Disinfection of Eyes
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
St. Olavs Hospital
Conditions:
Eye Infections
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
Topical povidone-iodine (PI) is widely used as ocular antiseptic before and after surgery. The standard dose of 5% PI is however, associated with ocular irritation. We therefore want to test if a lowe...
Eligibility Criteria
Inclusion
- Patients remitted to intravitreal injections at St. Olavs hospital.
- Patients competent to give written consent
Exclusion
- Infectious disease
- Known epitheliopathy
- Contact lens wear
- Use of prescription ophthalmic medications
- Diabetes
Key Trial Info
Start Date :
February 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04745663
Start Date
February 8 2021
End Date
April 30 2021
Last Update
September 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Olavs Hospital
Trondheim, Norway